PRPH
vs
AZN
PRPH
AZN
Over the past 12 months, PRPH has underperformed AZN, delivering a return of -95% compared to the AZN's +18% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
PRPH
AZN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Prophase Labs Inc
NASDAQ:PRPH
|
0.135
USD
|
|||||
|
AstraZeneca PLC
LSE:AZN
|
13 964
GBX
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
PRPH, AZN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Prophase Labs Inc
Revenue
|
|||||||||||
|
AstraZeneca PLC
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
PRPH, AZN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Prophase Labs Inc
NASDAQ:PRPH
|
|||||||||
|
AstraZeneca PLC
LSE:AZN
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
PRPH, AZN
Performance By Year
PRPH, AZN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.